Johnson & Johnson (JNJ) Reports 100% Success in OMNY-AF Study

Johnson & Johnson (NYSE:JNJ) is among the most profitable mega headdress stocks to buy. On February 6, Johnson & Johnson (NYSE:JNJ) disclosed 12-month pilot-phase information from the OMNY-AF study, which examined the investigational OMNYPULSE Platform for the attraction of symptomatic paroxysmal atrial fibrillation (AFib). Announced during the 31st Annual AF Symposium successful Boston, the results uncover that investigators achieved 100% acute procedural occurrence with zero adverse events linked to the procedure.

As stated by Dinesh Sharma, M.D., Section Head of Cardiac Electrophysiology astatine the Naples Heart Institute,

“The 12-month information supply encouraging aboriginal grounds connected the OMNY-AF survey with promising information outcomes – nary procedure-related adverse events oregon MRI-detected cerebral lesions – crossed 8 centers successful the aviator phase.”

Trong Nguyen / Shutterstock.com

Earlier connected February 3, RBC Capital accrued the terms people connected Johnson & Johnson (NYSE:JNJ) to $255 from $240 and reiterated an Outperform standing pursuing capitalist questions astir the Daubert determination related to talc litigation and however it volition interaction the institution financially.

According to the firm’s analysis, Johnson & Johnson (NYSE:JNJ) is improbable to overturn the cardinal consequences of the Daubert ruling, but the lawsuit whitethorn proceed for years. Despite this, the steadfast remains assured successful the healthcare giant’s fiscal position, fixed its beardown performance, which helps trim risk.

Johnson & Johnson (NYSE:JNJ) is simply a planetary healthcare institution focused connected innovative medicines and aesculapian technologies. Headquartered successful New Jersey, the institution serves a wide clientele, including retailers, wholesalers, healthcare professionals, and hospitals.

While we admit the imaginable of JNJ arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money.

Disclosure: None.